Authors
Yingjie Wang, Qingmin He, Hao Li, Tao Guo, Guizhi Wang, Xiang Li, Meng Fei, Yanjun Chen
Published in
Frontiers in oncology. Volume 16. Pages 1944908. Epub Sep 09, 2026.
Abstract
Unresectable locally advanced pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, particularly after distant metastasis. Irreversible electroporation (IRE) is a nonthermal ablative technique used for pancreatic tumors adjacent to major vessels, but evidence on late repeat pancreatic IRE remains limited. We report a 62-year-old man who presented with obstructive jaundice. Multidisciplinary evaluation classified the tumor as unresectable locally advanced PDAC involving the superior mesenteric vein-portal vein confluence. In January 2021, he underwent pancreatic IRE with biliary bypass, followed by sequential systemic therapy. Liver metastases developed approximately 10 months later and were treated locally, after which he continued multimodal therapy. In April 2025, gastroscopy revealed deformity and luminal narrowing of the duodenal bulb, accompanied by gastric retention, for which laparoscopic gastrojejunostomy was performed. In late 2025, a marked rise in carbohydrate antigen 19-9 (CA19-9) and tumor progression prompted multidisciplinary reassessment. Nearly 5 years after the initial procedure, he underwent repeat pancreatic IRE combined with radiofrequency ablation of a hepatic metastasis. During subsequent multimodal management, CA19-9 decreased from 12,280.0 to 291.4 U/mL. As of March 2026, he remained alive with disease, with an overall survival exceeding 62 months. This case demonstrates the technical feasibility of repeat pancreatic IRE after a prolonged interval and supports its potential role as an individualized local treatment within long-term multidisciplinary management.
PMID:
42779964
Bibliographic data and abstract were imported from PubMed on 24 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0